A multicenter analysis of implantable monitoring device-based diagnosis of supraventricular arrhythmia post patent foramen ovale closure: the OCCL-ILR study

In this multicenter retrospective analysis of patients undergoing percutaneous PFO closure with the Occlutech PFO device, implantable continuous rhythm monitoring devices were able to diagnose new-onset supraventricular arrhythmia (97% AF) after PFO closure in 31% of patients. While 94% of new-onset supraventricular arrhythmia events occurred in the first 45 days post-procedure, one-third of patients with arrhythmia post PFO closure presented AF episodes beyond 60 days post procedure.

Authors

Institutions

Publication Details

Journal
Frontiers in Cardiovascular Medicine
Published
2025-04-04
DOI
https://doi.org/10.3389/fcvm.2025.1541923
Primary Topic
Cardiovascular and Diving-Related Complications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A multicenter analysis of implantable monitoring device-based diagnosis of supraventricular arrhythmia post patent foramen ovale closure: the OCCL-ILR study

Philip Muyldermans, Steven Droogmans, Jean‐François Argacha, Liesbeth Rosseel et al.
Frontiers in Cardiovascular Medicine
Cardiovascular and Diving-Related Complications
article

A multicenter analysis of implantable monitoring device-based diagnosis of supraventricular arrhythmia post patent foramen ovale closure: the OCCL-ILR study

Philip Muyldermans, Steven Droogmans, Jean‐François Argacha, Liesbeth Rosseel, Maarten Pauwelyn, Andreea Motoc, Philippe Unger, Bram Roosens, Gian‐Battista Chierchia, Bernard Cosyns, Alvise Del Monte, Pieter‐Jan Palmers, Stijn Lochy, Frauke Gorré, Els Wirix, Sylvie De Raedt, Kurt Hermans, François Delvoye, Xavier Galloo, Danièle Plein, Julie Colas-Florial, Jonas Podevyn
article en

Abstract

In this multicenter retrospective analysis of patients undergoing percutaneous PFO closure with the Occlutech PFO device, implantable continuous rhythm monitoring devices were able to diagnose new-onset supraventricular arrhythmia (97% AF) after PFO closure in 31% of patients. While 94% of new-onset supraventricular arrhythmia events occurred in the first 45 days post-procedure, one-third of patients with arrhythmia post PFO closure presented AF episodes beyond 60 days post procedure.

Frontiers in Cardiovascular MedicineVol. 12
Vrije Universiteit Brussel (BE), Hart voor Research Aalst (BE), Onze Lieve Vrouwziekenhuis Hospital (BE), Universitair Ziekenhuis Brussel (BE), Clinic of Hope (BE), AZ Delta (BE), Flanders Environment Agency (BE), AZ Sint-Lucas (BE)
Good health and well-being
Openalex Percentile: Top 90%
Cardiovascular and Diving-Related Complications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.